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Abstract
Context: Development of optimal medicinal treatments of uterine leiomyomas represents a significant challenge. 2-
Methoxyestradiol (2ME) is an endogenous estrogen metabolite formed by sequential action of CYP450s and catechol-O-
methyltransferase (COMT). Our previous study demonstrated that 2ME is a potent antiproliferative, proapoptotic,
antiangiogenic, and collagen synthesis inhibitor in human leiomyomas cells (huLM).
Objectives: Our objectives were to investigate whether COMT expression, by the virtue of 2ME formation, affects the
growth of huLM, and to explore the cellular and molecular mechanisms whereby COMT expression or treatment with 2ME
affect these cells.
Results: Our data demonstrated that E2-induced proliferation was less pronounced in cells over-expressing COMT or treated
with 2ME (500 nM). This effect on cell proliferation was associated with microtubules stabilization and diminution of
estrogen receptor a (ERa) and progesterone receptor (PR) transcriptional activities, due to shifts in their subcellular
localization and sequestration in the cytoplasm. In addition, COMT over expression or treatment with 2ME reduced the
expression of hypoxia-inducible factor -1a (HIF-1 a) and the basal level as well as TNF-a-induced aromatase (CYP19)
expression.
Conclusions: COMT over expression or treatment with 2ME stabilize microtubules, ameliorates E2-induced proliferation,
inhibits ERa and PR signaling, and reduces HIF-1 a and CYP19 expression in human uterine leiomyoma cells. Thus,
microtubules are a candidate target for treatment of uterine leiomyomas. In addition, the naturally occurring microtubule-
targeting agent 2ME represents a potential new therapeutic for uterine leiomyomas.
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Introduction
Uterine leiomyomas are the most common benign gynecolog-
ical tumors in reproductive age women. It is estimated that the
incidence of uterine leiomyomas is over 80% in African-American
women by age 50, whereas Caucasian women have an incidence
of almost 70% at a similar age [1]. Although uterine leiomyomas
are benign tumors, they have a tremendous medical and
economical impact. Uterine leiomyomas are the leading indica-
tion for hysterectomy in the United States [2]. Myomectomy and
uterine artery embolization are also common treatments;
however, hysterectomy may be eventually required [3]. To date,
medical treatments for leiomyomas are limited and suboptimal
[4].
The development of medical treatment for uterine leiomyo-
m a si sh a m p e r e db yt h ef a c tt h a tm o l e c u l a rm e c h a n i s m s
underlying the development and progression of leiomyomas
are elusive. Substantial experimental and clinical evidence
indicates that steroid hormones (estrogens and progesterone)
and their cognate receptors are important etiologic factors in the
pathogenesis of leiomyomas [5]. Recently, Ishikawa H, et al [6]
reported that estrogen receptor subtype alpha (ERa)m R N A
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7356levels were 1.8 to 2.6-fold higher in uterine leiomyomas
compared with adjacent myometrium. Similarly, progesterone
r e c e p t o r sAa n dB( P R A&P R B )a r ee x p r e s s e da ts i g n i f i c a n t l y
higher levels in uterine leiomyomas compared to normal myo-
metrium [7,8].
The transcriptional activities of estrogen and progesterone
receptors are inherently regulated by microtubules (MT) dynamics
[9]. MT are highly dynamic polymers comprised of a/b-tubulin
heterodimers and their biological functions are largely regulated
by their polymerization/depolymerization dynamics [10,11]. By
providing scaffolding, sequestering, and delivery functions, MT
regulates nuclear receptors signaling pathways [12]. MT tether
steroid receptors and regulate their nuclear translocation as well as
the translocation of their signaling components [13]. It has been
reported that activation function 1 (AF1) domain of ERa binds to
a- and b-tubulins in MCF-7 breast carcinoma cells [14]. Indeed, it
has been reported that destabilization of MT activates ERa
transcriptional activity, whereas stabilization of MT represses ERa
transactivation [9].
2-Methoxyestradiol (2ME) is an endogenous 17 b-estradiol (E2)
metabolite with antimitotic, antiangiogenic, and proapoptotic
effects. It is also an inhibitor of collagen synthesis in human
leiomyoma cells [15] and has been described as MT targeting
agent in experimental models [16]. In this study, we tested the
hypothesis that 2ME or COMT gene over expression, by the
virtue of 2ME formation, inhibit the proliferation of human
leiomyoma cells by affecting MT dynamic which in turn regulate
the nuclear receptors signaling pathways. Our results suggest that
2ME, a naturally-occurring MTA, is a promising and safe medical
treatment of uterine leiomyomas.
Materials and Methods
Cell culture and establishing huLM cells expressing
different levels of COMT
The immortalized human uterine leiomyoma cell line (huLM),
which expresses both estrogen receptors (ERs) and progesterone
receptors (PRs), was a gift from Dr. Darlene Dixon (National
Institute of Environmental Health Sciences, Research Triangle
Park, NC). To evaluate the functional significance of COMT gene
expression on estrogen or progesterone and their respective
receptors signaling in huLM cells, we generated stable subcell-
lines from the parental huLM (huLM
W) cells that either
overexpressing COMT (huLM-COMT
KI) or underexpressing
COMT (huLM-COMT
KD). To establish huLM-COMT
KI cells,
the huLM were stably transfected with the pcDNA 3.1 (FLAG)
vector expressing the human membrane-bound isoform of COMT
cDNA using Fugene 6 Transfection Reagent (Roche Applied
Science, Indianapolis, IN) according to the manufacturer’s
protocol. Stable clones were selected in the presence of 1 mg/ml
of puromycin. Colonies resistant to puromycin appeared within 2
weeks, and the cells were then expanded for another 3 weeks to
make the original stock cells. Similarly, huLM-COMT
KD cells
were generated by stable transfection of the huLM
W as we
described before [17]. The cells were cultured and maintained as
previously described [18,15]. For hypoxic exposure, cells were
treated with CoCl2 (100 mM) for 8 hours.
Evaluation of E2-induced proliferation of huLM
expressing different COMT levels
We studied the effect of COMT expression or treatment with
2ME (500 nM) on E2-induced proliferation of human leiomyoma
cells. huLM
W, huLM-COMT
KD, EM-COMT
KI, or huLM cells
treated with 500 nM of (huLM
2ME) were plated in triplicate in 96-
well microplates at a density of 1610
4 cell/well in phenol-red free
media supplemented with 10% charcoal-stripped FCS. The cells
were then treated with 10
28 Mo fE 2. After 24, 48, 72 and 96 hr,
the cell numbers were determined using colorimetric (3-[4,5-
dimethylthiazol-2-yle] 2,5-diphenyltetrazolium bromide) (MTT)
assay as described before [17].
Flow cytometry analysis of cell cycle distribution
E2-induced cell cycle progression of huLM
W, huLM-COMT
KI,
huLM
2ME, and huLM-COMT
KD was assessed by flow cytometry.
The cells were treated with E2 (10
28 M) for 24 hr. The cells were
harvested and stained with Propidium iodide as described before
[17]. The DNA content of the cell samples was analyzed by
FACScan Scanford flow cytometer (BD Biosciences, San Jose, CA)
with an argon laser turned to 488 nm for excitation. The red
fluorescence of Propidium iodide was measured at 670 nm. For
each experiment, 2610
4 cells were analyzed by flow cytometry.
Data were analyzed using CellQuest software (BD Biosciences,
San Jose, CA). Each independent experiment was carried out 3
times
Transient transfection and luciferase reporter gene assay
The effect of COMT gene expression or treatment with 2ME
(500 nM) on the estrogen receptor signaling in huLM was
determined using an estrogen-responsive reporter in the adeno-
viral vector (Ad-ERE-luc), as described previously [19]. Similarly,
progesterone receptor signaling was assessed by transfecting cells
with 1 mg of the progesterone-responsive reporter plasmid pPRE/
GRE.E1b.Luc (kindly provided by Dr. Ming-Jer Tsai, Baylor
College of Medicine, Houston, TX) using Fugene 6 transfection
reagents as described before [17]. Briefly, huLM
W,h u L M -
COMT
KI, huLM-COMT
KD,o rh u L M
2ME were grown in
charcoal-stripped, phenol red-free medium for 2 days. The cells
were then transfected with Ad-ERE-Luc (50 PFU/cell) or pPRE/
GRE.E1b.Luc. The next day, media were replaced with fresh
m e d i ac o n t a i n i n g1 0
28 ME 2 (for estrogen receptor signaling) or
100 nM of progesterone (P4) (for progesterone receptor signal-
ing). Forty-eight hours later, luciferase activities were determined
using luciferase enzyme assay systems as previously described
[17]. The luciferase activity was normalized against protein
concentrations.
Preparation of total cell lysates, nuclear fraction, and
cytoplasmic fraction
The huLM
W, huLM
2ME, huLM COMT
KI or huLM COMT
KD
were treated with E2 (10 nM) or P4 (100 nM) for 30 min. Total
cell lysates, nuclear and cytoplasmic fractions were prepared using
the NE-PER nuclear extraction kit (Pierce, Rockford, IL),
according to the manufacturer’s instructions. Protein concentra-
tion was determined by Bradford assay (Bio-Rad Laboratories,
Inc., Hercules, CA) using BSA as a standard. The extracts were
saved at 280uC until used for immunoblotting of estrogen and
progesterone receptors.
Microtubule assay
To assess the effect of COMT expression or 2ME (500 nM) on
the microtubule dynamics in huLM, we measured the free and
polymerized tubulin in huLM
W, huLM-COMT
KD, huLM–
COMT
KI, or huLM
2ME using microtubules/tubulin assay kit
(Cytoskeleton, Inc, Denver, CO), according to the manufacturer’s
instruction. Briefly, cells were homogenized via syringe trituration
and incubated for 10 minutes in lysis buffer. A volume of 10 mLo f
cell homogenates was saved for protein measurement using the
2ME and Microtubules Dynamics
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100,0006g for 30 minutes to separate microtubules from free-
tubulin. The polymerized microtubules settle in the pellet, while
the free-tubulin remains in the supernatant. Following centrifuga-
tion, the supernatant (free-tubulin) was removed and frozen until
Western blot analysis. The pellet was resuspended in ice-cold
water containing CaCl2 (200 mM) and incubated for one hour.
CaCl2 acts to enhance microtubule depolymerization [20]. Thus,
the microtubules remaining in the pellet were depolymerized to
free-tubulin. The samples were then centrifuged at 14,0006g( 4 uC)
for 10 minutes. The supernatant (containing free-tubulin repre-
senting the original microtubules) was collected and frozen.
Tubulin concentrations in both fractions were measured using
Western blotting
Immunofluorescence and Confocal Microscopy
huLM
W, huLM-COMT
KI, huLM
2ME, or huLM-COMT
KD
were grown on glass cover slips. Cells were treated with E2
(10 nM) or P4 (100 nM) for 30 min and then fixed in 4%
formaldehyde, permeabilized with 0.2% Triton X-100 for 10
minutes, and incubated in 10% BSA/PBS for 1 hour to block
nonspecific protein-binding sites. Subsequently, cells were incu-
bated overnight at 4uC with primary antibodies against ERa
(1:100 Ab-10, Thermo Fisher Scientific Inc. Fremont, CA) or PR
(1:100 Ab-7 Thermo Fisher Scientific Inc. Fremont, CA), followed
by mouse fluorescein isothiocyanate–labeled secondary antibodies
(Jackson ImmunoResearch Laboratories, Inc. PA). Nuclei were
stained with DAPI dye. Samples were analyzed using a Zeiss
LSM510 Meta Confocal Microscope. Lasers power, beam
splitters, filter settings, pinhole diameters, and scan mode were
the same for all examined samples. Fields in the figures are
representative of all examined fields.
Immunoblotting
Immunoblotting was performed as previously described [19].
The antibodies used for immunoblotting were, mouse monoclonal
antibody raised against Progesterone Receptor Ab-8 (Clone hPRa
2+hPRa 3) (Thermo Fisher Scientific, Fremont, CA), mouse
monoclonal antibody to Estrogen Receptor alpha (Abcam Inc.,
Cambridge, MA), mouse monoclonal antibody against tubulin
(Cytoskeleton, Inc, Denver, CO), rabbit monoclonal antibody
against COMT (Chemicon International Inc., Temecula, CA);
and mouse monoclonal antibody against HIF-1a (Novus Biolog-
ical, LLC, Littleton, CO). Mouse monoclonal antibody against b-
actin (Sigma-Aldrich Co., St. Louis, MO) was used to confirm
equal loading.
RNA extraction and quantitative analysis of CYP19 using
real-time RT-PCR
To determine the effect of COMT expression or treatment with
2ME on basal as well as TNF-a-induced Aromatase (CYP19)
expression in huLM
W; huLM
2ME; huLM-COMT
KD; and huLM-
COMT
KI, cells were treated with TNF-a (20 ng/ml) for 48 hrs.
RNA extraction and real-time RT-PCR for CYP19 expression
were performed as previously described [21]. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) transcripts were measured as
an internal control.
Data Analysis
Measurements are reported as the mean 6 SEM. The statistical
significance of mean differences was determined by Student’s t test.
A value of p#0.05 was considered statistically significant.
Results
Effect of COMT expression or treatment with 2ME on
growth and cell cycle distribution of huLM
To assess the effect of COMT expression on huLM cells, we
established the sub cell-lines huLM-COMT
KI and huLM-
COMT
KD from the parental huLM (huLM
W) (Figure 1A). Prior
to the principal experiments, we validated the functional
significance of COMT expression on the 2ME level. As expected,
2ME levels were 375623, 834634, and 153618 (pmole/mg
protein/hour) in huLM-COMT
w, huLM-COMT
KI, and huLM-
COMT
KD; respectively (figure 1B).
To investigate whether the effect of COMT expression on the
proliferation of huLM cells is E2-dependent, we assessed the
proliferation of huLM
W, huLM-COMT
KD, huLM-COMT
KI, and
huLM
2ME grown in estrogen-deprived media. As indicated in
figure 2A, in absence of estrogen, proliferation rate of huLM-
COMT
KD and huLM-COMT
KI is very similar to that of huLM
w,
while, the proliferation of huLM-COMT
2ME is significantly less
that of huLM
w (Figure 1A).
Subsequently, we investigated the role of COMT expression or
treatment with 2ME (500 nM) on E2-induced huLM proliferation.
Our data demonstrated that the rate of E2 (10 nM)-induced
Figure 1. COMT expression and 2ME production by huLM
2ME,
huLM-COMT
KI, huLM-COMT
KD and huLM
W. (A) Immunoblotting of
COMT expression in huLM
W, huLM-COMT
KI, and huLM-COMT
KD. HuLM
W
cells were stably transfected with either COMT-cDNA or COMT-shRNA
constructs. The stably transfected cells were then selected as described
under Materials and Methods section. COMT expression in selected
colonies was determined using Western blot analysis. MB-COMT:
membrane-bound COMT; S-COMT: soluble COMT. (B) Level of 2ME in
culture media from huLM
W, huLM-COMT
KI and huLM-COMT
KD. Cells
were grown in serum-free media and treated with E2 (10 nM) for 48 h.
Media were collected to quantify different 2ME by HPLC-electrospray
ionization-tandem mass spectrometry. Data were normalized against
protein concentration. * Significantly (P,0.05) higher compared with
huLM
W; ** significantly (P,0.05) lower than huLM
W.
doi:10.1371/journal.pone.0007356.g001
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KD
. huLM
w . huLM-COMT
KI $ huLM
2ME (Figure 2B).
Furthermore, we assessed the cell cycle distribution in huLM
W,
huLM
2ME, huLM-COMT
KI, and huLM-COMT
KD following
exposure to E2 (10 nM) for 24 hours. As indicated in figure 2C,
the percentages of cells in S-phase of cell cycle were 4663.1,
3662.9, 3862.4, and 5863.2; in huLM
w, huLM
2ME, huLM-
COMT
KI, and huLM-COMT
KD, respectively. These data
indicate that COMT over expression or treatment with 2ME
ameliorate E2-stimulated cell cycle progression. Thus, COMT
over expression and 2ME (500 nM) represent an integral system
that modifies the biological response of huLM cells, and therefore
we will refer to them collectively as COMT/2ME
Effect of COMT expression and 2ME on microtubule
dynamics
Substantial evidence indicates that 2ME is a microtubule
targeting agent [16]. Thus, it is possible that COMT over
expression could also exert a similar effect. Therefore, we wanted
to determine whether COMT expression or treatment with 2ME
(500 nM) affect the relative abundance of free and polymerized
microtubule, as a measure of changes in microtubule dynamics.
Immunoblotting analysis demonstrated that the ratio of free to
polymerized tubulin is slightly high in huLM
W and huLM-
COMT
KD, whereas it is considerably low in huLM-COMT
KI and
huLM
2ME (Figure 3A). Densitometric measurements showed that
the amount of free/polymerized tubulin (expressed as arbitrary
unit), was 460.16/360.09, 2.560.11/4.560.12, 560.13/
260.09, and 5.2 60.1/1.860.05 respectively; in huLM
W,
huLM-COMT
KD, huLM-COMT
KI, and huLM
2ME, respectively
(Figure 3B). Thus, our data suggest that COMT/2ME shift the
equilibrium of free to polymerized tubulin to favor microtubules
polymerization.
Effect of COMT/2ME on Steroid receptors transcriptional
activities
Estrogen and progesterone receptors are crucial for the growth
of uterine leiomyomas and it has been reported that microtubules
dynamics play an inherent role in their transcriptional activities
Figure 2. Proliferation and cell cycle progression in huLM
2ME,
huLM-COMT
KI, huLM-COMT
KD and huLM
W. (A) Proliferation of
huLM cells expressing different levels of COMT or treated with 2ME
(500 nM) in absence of estrogen. The cells were cultured in phenol red-
free medium containing 10% of charcoal-stripped fetal calf serum. MTT
assay was used to determine the E2-independent proliferation rates of
huLM
W, huLM-COMT
KD; huLM
2ME, and huLM-COMT
KI cells. Cells (1,000/
well) were seeded in 96-well microplates. After 24, 48, 72 and 96 hr, the
number of viable cells was determined by reading the optical density at
a wavelength of 595 nm with a reference wavelength of 650 nm. Data
are representative of 3 independent experiments. *a, significantly
(P,0.05) lower compared with huLM
W. *b, significantly (P,0.05) lower
compared with huLM
W. (B) E2-induced proliferation of huLM cells
expressing different levels of COMT or treated with 2ME (500 nM). Data
are representative of 3 independent experiments. *a, significantly
(P,0.05) higher compared with huLM
W. *b, significantly (P,0.05) lower
compared with huLM
W. (C) Effects of COMT expression level or
treatment with 2ME (500 nM) on E2-provoked huLM cell cycle
progression. Flow cytometry using Propidium Iodide labeling of nuclei
was done to determine percentage of cells in S-phase of the cell cycle.
Data are representative of 3 independent experiments. *a, significantly
(P,0.05) lower compared with huLM
W. *b, significantly (P,0.05) higher
compared with huLM
W.
doi:10.1371/journal.pone.0007356.g002 Figure 3. Relative abundance of free and polymerized tubulin
in huLM
2ME, huLM-COMT
KI; huLM-COMT
KD and huLM
W. (A)
Representative gel (30 mg of protein for each sample) displaying free
and polymerized tubulin. (B) Graph summarizing data from three
independent experiments with levels of free and polymerized tubulin
expressed in arbitrary units. *a significantly (P,0.05) lower than huLM
W
or huLM-COMT
KD * b significantly (P,0.05) higher compared with
huLM
W or huLM-COMT
KD.
doi:10.1371/journal.pone.0007356.g003
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may eventually affect the signaling function of ERa and PRs in
huLM. Therefore, we evaluated the transactivation capacity of
ERa in huLM with different levels of COMT expression or
treated with 2ME (500 nM). Compared with parental huLM
W,
E2-induced ERE-luc activities were reduced by 4362.6% and
49.362.4%, in huLM-COMT
KI and huLM
2ME, respectively. In
contrast, E2-induced ERE-luc activity in huLM-COMT
KD was
increased by 4061.7% compared to huLM
W (Figure 4A).
Similarly, we demonstrated that Progesterone (P4)-induced
pPRE/GRE.E1b.Luc activities in huLM
2ME and huLM-
COMT
KI were significantly reduced to 55.363.2% and
49.764.6%, respectively, from the huLM
W. However, P4-induced
pPRE/GRE.E1b.Luc activity in huLM-COMT
KD was not
different from huLM
W (Figure 4B). Thus, COMT/2ME affects
the transcriptional activity of ERa and PRs in huLM.
Effect of COMT/2ME on the expression and localization of
Steroid receptors
To understand how COMT/2ME affects proliferation and
steroid receptors signaling in huLM, we assessed the total level
and the subcellular localization of ERa and PRs in huLM
W,
huLM
2ME huLM-COMT
KIand huLM-COMT
KD.W e s t e r nb l o t
analysis revealed that there was no significant difference in the
total amount of ERa in huLM
W,h u L M
2ME, huLM-COMT
KI
and huLM-COMT
KD (Figure 5). However, our data revealed
that COMT/2ME alters the subcellular localization of ERa.I n
huLM
W or huLM-COMT
KD cells treated with E2 (10 nM for
30 min), the vast majority of ERa was localized in the nuclear
fraction, with minimal amount retained in the cytoplasmic
fraction (Figure 5A). On the other hand, in huLM-COMT
KI and
huLM
2ME treated with E2,t h eE R a in the nuclear fraction was
reduced with parallel increase in ERa retained in the
cytoplasmic fraction (Figure 5A). Thus, COMT/2ME reduces
nuclear shuttling of ERa without any significant change in the
expression level of total ERa.S i m i l a r l y ,w ea s s e s s e dt h ee f f e c to f
COMT/2ME on the total level and the subcellular localization
of PRs. As indicated in figure [6], COMT over expression or
treatment with 2ME resulted in an apparent decrease in the total
PRs level. This decrease in total PR level was associated with, a
decrease in PR nuclear translocation, and increased retention
PRs in the cytoplasmic fraction upon treatment with P4
(100 nM, for 30 min) (Figure 6). Thus, COMT/2ME decreases
PRs expression and reduces their nuclear translocation as well.
The effect of COMT/2ME on the subcellular localization of
ERa and PRs was also confirmed by confocal microscopy
(figures 5B and 6B).
2ME reduces the expression of HIF-1a
The activity of hypoxia inducible factor 1 alpha (HIF-1a), a
hallmark of hypoxia, is blocked by 2ME via disruption of MT
dynamics [22]. Accordingly, we investigated the effect of COMT/
2ME on the basal as well as hypoxia-induced expression of HIF-1a
in huLM. Our data demonstrated that HIF-1a is constitutively
expressed in huLM under normoxic condition and is further
increased by CoCl2-induced hypoxia (Figure 7). Interestingly, the
basal level and hypoxia-induced HIF-1a are significantly low in
huLM
2ME and huLM-COMT
KI compared with huLM
W
(Figure 7).
COMT/2ME antagonizes TNF-a-induced aromatase
(CYP19) expression in huLM
Experimental evidence suggests that microtubule stabilizers,
including 2ME, inhibit the basal and TNF-a-induced CYP19
expression in breast stromal fibroblasts [23]. Thus, we investigated
the effect of COMT/2ME on CYP19 expression in huLM. Our
data demonstrated that COMT/2ME reduces both basal as well
as TNF-a-induced CYP19 expression. CYP19 basal expression
level in huLM-COMT
KI and huLM
2ME was reduced by 50% and
70%, respectively, compared to the huLM
W. In huLM
W, TNF-a
(20 ng/ml) increases CYP19 expression by 190% from basal level.
However, in huLM
2ME and huLM-COMT
KI, TNF-a increases
CYP19 expression only by 50% and 40%, respectively, from
corresponding basal levels (Figure 8).
Discussion
Our previous findings showed that 2ME targets human
uterine leiomyoma cells through multiple mechanisms, includ-
ing its effects on proliferation, angiogenesis, apoptosis, as well
as collagen synthesis [15]. The current study was undertaken to
investigate the molecular mechanisms underlying these effects.
We have further examined whether manipulation of COMT
expression, by the virtue of 2ME formation, can affect
leiomyoma cells. Our data show that 2ME (500 nM) halts E2-
Figure 4. Transcriptional activity of E2 and P4 in huLM
2ME,
huLM-COMT
KI; huLM-COMT
KD and huLM
W. (A) Effect of E2 on
transcription activity of ERa in huLM
W; huLM
2ME; huLM-COMT
KD; and
huLM-COMT
KI Cells were transfected with 50 PFU/cell of adenovirus-
ERE-luc as described in materials and methods section. Cells were
treated with E2 (10 nM) for 48 hr. Luciferase activities were expressed as
percentage of that obtained with huLM
W which was given a value of
100%. Values represent the mean 6 SEM of three independent
experiments. (B) Effect of P4 (100 nM) on transcriptional activity of
progesterone receptor in huLM
W; huLM
2ME; huLM-COMT
KD; and huLM-
COMT
KI Cells were transfected with pPRE/GRE.E1b. Luc constructs as
described in materials and methods section. Cells were treated with P4
(100 nM) for 48 hr. Luciferase activities were expressed as percentage
of that obtained with huLM
W which was given a value of 100%. Values
represent the mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0007356.g004
2ME and Microtubules Dynamics
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ization, attenuates nuclear receptors signaling, antagonizes
TNF-a–induced CYP19 expression, and decreases HIF-1a
protein levels. Interestingly, our results suggest that COMT
overexpression produces effects similar to 2ME treatment.
Although COMT is constitutively expressed in huLM cells, this
expression level and the resultant concentration of 2ME is
lower than the minimum concentration that can affect
proliferation of these cells. We previously demonstrated that
2ME affects huLM
W proliferation at concentrations more than
200 nM [15]. Based on results from measuring 2ME level in
Figure 5. Expression and cellular localization of ERa in huLM
W;
huLM
2ME; huLM-COMT
KD; and huLM-COMT
KI. (A) Expression and
cellular localization of ERa in huLM
W; huLM
2ME; huLM-COMT
KD; and
huLM-COMT
KI. Cells were treated with E2 (10 nM, for 30 min) and total
cell lysates, nuclear fraction, and cytoplasmic fraction were prepared as
described in the materials and methods section. ERa expression in
different cellular fractions was determined using Western blot analysis.
(B). Immunofluorescence microscopic imaging of ERa in huLM
W, huLM-
COMT
KD, huLM–COMT
KI, or huLM
2ME. Immunofluorescent staining with
ERa antibody (green) in huLM
W, huLM-COMT
KD, huLM–COMT
KI,o r
huLM
2ME, counterstaining with DAPI (blue), and merged images (Merge)
are shown. All images were captured with same time exposure using a
Zeiss confocal microscope
doi:10.1371/journal.pone.0007356.g005
Figure 6. Expression and cellular localization of PRs in huLM
W;
huLM
2ME; huLM-COMT
KD; and huLM-COMT
KI. (A) Expression and
cellular localization of PRs in huLM
W; huLM
2ME; huLM-COMT
KD; and
huLM-COMT
KI. Cells were treated with P4 (100 nM, for 30 min) and total
cell lysates, nuclear fraction, and cytoplasmic fraction were prepared as
described in the materials and methods section. PRs expression was
determined in different cellular fractions using Western blot analysis. (B)
Immunofluorescence microscopic imaging of PR in huLM
W, huLM-
COMT
KD, huLM–COMT
KI, or huLM
2ME. Immunofluorescent staining with
PR antibody (green) in huLM
W, huLM-COMT
KD, huLM–COMT
KI,o r
huLM
2ME, counterstaining with DAPI (blue), and the merged images
(Merge) are shown. All images were captured with same time exposure
using a Zeiss confocal microscope
doi:10.1371/journal.pone.0007356.g006
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inhibit cell proliferation or affect the cytoskeleton is not
attainable under the normal expression level of COMT. This
finding may indicate COMT/2ME represents an integral
system, with 2ME the proximal effector that regulates uterine
leiomyomas growth.
Our study suggests that the effects of COMT/2ME on huLM
are mediated by disturbing microtubule dynamics. Microtubules
provide structural support and modulate signal transduction of
several molecules involved in uterine leiomyomas development.
For instance, ERa and PRs signaling, which are crucial for growth
of uterine leiomyomas [24], are inherently regulated by microtu-
bule dynamics [9,25].
By providing scaffolding, sequestering, and delivery functions,
microtubules are involved in nuclear receptors signaling pathways
[12]. In addition, microtubules tether steroid receptors and
regulate their nuclear shuttling as well as the translocation of
their signaling components [13,26]. Thus, COMT/2ME-induced
microtubule stabilization leads to cytoplasmic retention and
nuclear compartmentalization impairment of ERa and PRs, and
consequently leiomyoma cells growth arrest.
Interestingly, COMT/2ME exerts a dual effect on PRs as it
inhibits both total protein expression and nuclear localization. The
effect of COMT/2ME on PRs nuclear localization could be
explained by microtubule stabilization. Meanwhile, reduction in
total PRs expression may be a consequence of attenuation ERa
signaling, which is a key regulator of PRs expression.
In addition to the effect on steroid receptors signaling, our data
demonstrated that COMT/2ME reduces both basal and TNF-a-
induced CYP19 expression. CYP19 expression promotes the
development and progression of uterine leiomyomas by mediating
in situ estrogen biosynthesis [27]. Indeed, it has been established
that CYP19 expression is strikingly higher in uterine leiomyoma
compared to adjacent myometrium [28,29]. The effect of
COMT/2ME on CYP19 expression is consistent with a previous
report that microtubule stabilizers, including 2ME, inhibits basal
as well as TNF-a-induced CYP19 expression in estrogen
responsive cells [23]. The ability of COMT/2ME to reduce basal
(i.e. unstimulated) CYP19 expression may result from blocking the
autocrine/paracrine actions of cytokines and PGE2, which are
known inducers of CYP19 in leiomyomas cells [6]. In fact, it has
been reported that 2ME, through microtubule stabilization,
inhibits cytokines and PGE2-induced CYP19 expression in
fibroblasts [23]. TNF-a-induced CYP19 expression in huLM is
consistent with our previous finding that TNF-a induces CYP19
expression in endometrial cells [30]. It has been reported that
microtubules play a role in nuclear transport of NF-kB [31], as
well as NF-kB-dependent transcription activity [32]. It is likely,
therefore, that COMT/2ME-induced microtubule stabilization
inhibits the nuclear translocation of NF-kB in huLM and
therefore, CYP19 expression.
Another critical factor for the uterine leiomyomas growth is
the transcription factor HIF-1a which regulates the expression of
growth factors and profibrotic mediators, such as platelet-
derived growth factor, fibroblasts growth factor-2, plasminogen
activator inhibitor-1, and connective tissue growth factor [33].
The products of these genes are known to influence cell
proliferation and extracellular matrix turnover which are critical
processes in leiomyoma growth [34,35,36,37]. Our data
demonstrated that huLM cells express a constitutive level of
HIF-1a, which is significantly increased by CoCl2-induced
hypoxia. Intriguingly, COMT/2ME inhibited both basal and
hypoxia-induced HIF-1a expression in huLM. The effect of
COMT/2ME on HIF-1 a is probably a consequence of
microtubule stabilization. Indeed, it has been reported that
disruption of microtubule dynamics, both by microtubule-
stabilizing and microtubule-destabilizing agents, inhibits HIF-1
a expression and activity [38].
Thus, COMT/2ME exerts several therapeutic effects on huLM.
It inhibits steroid nuclear receptor signaling, reduces aromatase
gene expression, and down-regulates HIF-1 a expression. These
pleiotropic therapeutic effects of COMT/2ME on huLM suggest
that microtubule targeting agents could represent a potential new
therapeutic for uterine leiomyomas. Considering the fact that it is
an orally-active natural metabolite, with excellent safety profile in
human, 2ME represents a potential medicinal treatment for
uterine leiomyomas. Pre-clinical studies to support its use in
uterine leiomyomas can be initiated
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Figure 7. Effect of COMT expression or treatment with 2ME
(500 nM) on basal and hypoxia-induced HIF-1a protein levels
in huLM. (A) Western blot analysis of basal level of HIF-1a in whole cell
extracts from huLM
W; huLM
2-ME, huLM-COMT
KD, and huLM-COMT.
KI (B)
HIF-1a level in huLM
W; huLM
2ME; huLM-COMT
KD; and huLM-COMT
KI
incubated for 8 h with CoCl2 (100 mM).
doi:10.1371/journal.pone.0007356.g007
Figure 8. Effect of COMT expression or treatment with 2ME
(500 nM) on basal and TNF-a-induced CYP19 mRNA expression
in huLM
W, huLM
2ME, huLM-COMT
KD, and huLM-COMT
KI . Cells
were treated with TNF-a (20 ng/ml) for 48 hours. CYP19 mRNA
expression levels were measured by real-time RT-PCR and were
normalized to GAPDH mRNA. Levels are reported as fold change
compared with basal level detected in huLM
W.
doi:10.1371/journal.pone.0007356.g008
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